Friday, 27 February 2015
It would be tough for FDA to track whether a traditional compounding facility, which is not required to register with the agency, is limiting its compounding of drugs to specific indications, said an FDA official at a Pharmacy Compounding Advisory Committee meeting Tuesday (Feb. 24).
No comments:
Post a Comment